arrow
Ł

Łukasz Galus

Poznan University of Medical Sciences
H指数:13
被引数:414

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characteristics of Intestinal Barrier State and Immunoglobulin-Bound Fraction of Stool Microbiota in Advanced Melanoma Patients Undergoing Anti-PD-1 Therapy

肠道屏障状态及粪便微生物群免疫球蛋白结合分数的特征:接受抗PD-1疗法治疗的晚期黑色素瘤患者

2026-03-030
OAAI
Discontinuation of Immune Checkpoint Inhibition in Patients with Advanced Unresectable Melanoma Achieving CR, PR, or SD

晚期不可切除黑色素瘤患者免疫检查点抑制停药后达到完全缓解(CR)、部分缓解(PR)或疾病稳定(SD)的研究

2025-06-240
OAAI
Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapy

探索黑色素瘤患者接受抗PD-1治疗期间肠道真菌组与淋巴细胞之间的相关性

2025-02-250
OA
Comparison of efficacy and toxicity of dabrafenib/ trametinib versus vemurafenib/cobimetinib therapy in routine medical practice: Eight years of BRAF/MEK inhibitor use in routine clinical practice
2023-10-011
PRE
Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients-Real-World Evidence

BRAF突变的晚期皮肤黑色素瘤患者一线免疫治疗后靶向治疗的长期结果-现实世界证据

2022-04-175
OAAI
Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patients
2018-08-2416
OAAI